Interventions to Improve Non-Malarial Fever Diagnosis in Mobile Health Clinics in Mulanje, Malawi |
Fiona Sylvies, MS |
Infectious Disease, Drug and Diagnostics Development |
|
|
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin |
|
HIV/AIDS, Immunology |
|
|
Reducing Breast Cancer Risk in Korean American Women |
Janice Tsoh, PhD |
Cancer/Oncology, Genetics, Immigration and Migration |
|
|
Investigating Mechanisms of HIV Persistence in the Gut |
Peter Hunt, MD |
HIV/AIDS, Immunology |
|
|
Alcohol's impact on immunological and virological profiles in HIV patients |
Mandana Khalili, MD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
Investigating ASPM regulation of asymmetric division for therapeutic opportunities |
|
Genetics |
|
|
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV |
|
HIV/AIDS, Immunology |
|
|
Integrative Program in Complex Biological System (ipCBS) |
Joseph Derisi, PhD |
Drug and Diagnostics Development, Immunology, Genetics, Residencies, Fellowships, and Postdoctoral Training |
|
|
Validation of the GeneXpert Breast Cancer STRAT4 Assay for Rapid Analysis of Breast Cancer Biomarker Status from Fine Needle Aspiration Biopsies in Tanzania (GX-BCB |
Dianna Ng, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Novel Linkers for Antibody-Drug Conjugates |
Adam Renslo, PhD |
Immunology |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Microbial Pathogenesis and Host Defense |
Joanne Engel, MD, PhD |
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
An implantable hemodialyzer for treatment of End-Stage Renal Disease |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Macular Edema Treatment Trials Associated with MUST (META-MUST) |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling |
Sulggi Lee, MD |
HIV/AIDS, Immunology |
|
|
Image-Based Numerical Predictions of Hemodynamics following Vascular Intervention |
David Saloner, PhD |
Cardiovascular Disease, Drug and Diagnostics Development, Neurology and Mental Health |
|
|
Multi-Institutional Randomized Controlled Trial Evaluating Use of Arista Absorbable Surgical Hemostatic Powder |
Rahul Seth, MD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Role of Antigen-Specific T Cell Responses in the Control of TB |
Joel D. Ernst, MD |
Tuberculosis, Immunology |
|
|
HPTN 082 - Protocol Implementation Funding |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Richer Models of Asthma Risk: Bridging the Environment-Genetics Divide |
|
Chronic Respiratory Disease, Occupational and Environmental Disease, Genetics |
|
|
Exhaled Breath Biomarkers for the Diagnosis of TB in Children |
Devan Jaganath, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Combination immune checkpoint blocker inhibition to eliminate HIV latency |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
The Ethics of Inclusion: Diversity in Precision Medicine Research |
Janet K. Shim, PhD |
Genetics |
|
|
Accurate and unbiased single cell sequencing with digital droplet MDA |
Adam Abate, PhD |
Genetics |
|
|
Trefoil Factor Proteins Modulate Host Immunity against Hookworms |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Physical and Genetic Interaction Landscape of the Tyrosine Kinome |
Nevan Krogan, PhD, MSc |
Cancer/Oncology, Diabetes, Immunology |
|
|
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Genetics, Pharmacology and Drug Treatment, Pediatrics |
|
|
Novel methods for monitoring long-term drug exposure and resistance amplification during treatment of multidrug resistant tuberculosis |
John Metcalfe, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Microfluidic immunoprofiling for biomarker discovery in rheumatoid arthritis |
Adam Abate, PhD |
Immunology |
|
|
Functional Manipulation of Memory Regulatory T cells in Skin |
|
Cancer/Oncology, Immunology |
|
|
1/3 Multidimensional investigation of the etiology of autism spectrum disorder |
|
Genetics, Neurology and Mental Health |
|
|
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Host Genetics of HIV: Enhancing Discovery through Study Design and New Tools |
Ruth Greenblatt, MD |
HIV/AIDS, Genetics |
|
|
Population genetic analysis and regional variation |
Kicheol Kim, PhD |
Genetics |
|
|
Detection of C. trachomatis on eye swabs |
Julius Schachter, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Generation of therapeutic antibodies for serotype F botulism (Continuation of A120963 from NIH G Pool to Subaccount) |
|
Immunology |
|
|
Phase III Quinolone Meta-Analysis |
Rada Savic, PhD |
Drug and Diagnostics Development |
|
|
Mechanisms of nanostructure-enhanced transepithelial drug delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Host-Directed Strategies to Create Synergistic Antibacterial Therapies |
|
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development, Immunology |
|
|
Naturally acquired immunity to norovirus in a newborn cohort in Peru |
Caryn Bern, MD, MPH |
Infectious Disease, Immunology, Newborn and Infant Health |
|
|
A Multi-Centric Evaluation of a Device for Automated Malaria Microscopy (EasyScan Go) |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Peter Hunt, MD |
Immunology |
|
|
Transition zone control of ciliary signaling |
Jeremy Reiter, MD, PhD |
Genetics |
|
|
VEGF signaling in placental development and disease |
Susan Fisher, PhD |
Immunology, Labor and Delivery |
|
|
Metagenomic Contributions to Type 2 Diabetes Among Filipino Populations |
Mark Seielstad, PhD |
Transfusion Medicine, Diabetes, Genetics, Epidemiology and Surveillance |
|
|
Discovery of Oxaboroles as New Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Influence of Heme on Hepatic Cytochrome P450 Turnover |
Maria Correia, PhD |
Drug and Diagnostics Development |
|
|
Integrative Pharmacology Approach to Understand Mechanisms of Tuberculosis Drug Resistance |
Rada Savic, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Career: Massively-Parallel Single-Cell Genomics and Transcriptomics with Droplet Microfluidics |
Adam Abate, PhD |
Drug and Diagnostics Development |
|
|
Natural Bacteriocins as Pre/Pro-Biotics to Promote Oral Health and Prevent Periodontal Disease |
Yvonne Kapila, DDS, PhD |
Oral Health, Drug and Diagnostics Development |
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Genetics |
|
|
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness |
|
Cancer/Oncology, Immunology |
|
|
Genetic and epigenetic contributions to Sjogrens syndrome |
|
Eye Disease and Blindness, Oral Health, Genetics |
|
|
HVTN 703/HPTN 081 Protocol Funding (PF) |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health |
|
|
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Genomic research on the African diaspora |
Ian Whitmarsh, PhD |
Genetics |
|
|
Validation of candidate ASD genes by targeted sequencing with molecular inversion probes |
|
Genetics, Neurology and Mental Health |
|
|
2 year joint fellowship program in Clinical Pharmacy with Actelion |
Francesca Aweeka, PharmD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment, Residencies, Fellowships, and Postdoctoral Training |
|
|
Antigen Specificity of Regulatory T cells in Type 1 diabetes T1D |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence |
Constance Weisner, DrPH |
Drug and Diagnostics Development, Substance Abuse |
|
|
Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS) (Survey ID: Fx-R-001) |
Jeffrey Ralph, MD |
Genetics, Neurology and Mental Health |
|
|
Whole Genome Sequence Characterization of Drug Resistant Malarial Strains |
Sumayya Mohammed, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Genetics |
|
|
Factors Associated with G6PD Deficiency Testing Adherence Among P. vivax RDT-positive Individuals Living in Southern Lao PDR |
Resego Bokete, MS |
Malaria, Drug and Diagnostics Development |
|
|
Allosteric Inhibition of a Family of Proteolytic Enzymes |
Charles Craik, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
A Program of Research in Population Cytogenetics |
Tracey Woodruff, PhD, MPH |
Occupational and Environmental Disease, Genetics, Newborn and Infant Health |
|
|
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma |
Anita Sil, MD, PhD |
Opportunistic Infection, Immunology |
|
|
Intervascular Capsule for Islet Transplantation in Type I Diabetic Patients |
Shuvo Roy, PhD |
Diabetes, Drug and Diagnostics Development |
|
|
Multi-center evaluation of improved RT-QuIC diagnostic assays for Creutzfeldt-Jakob and other human prion diseases |
Michael Geschwind, MD, PhD |
Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
Phase 1 Train of Na-APR-w and Na-GST-1 Hookworm Vaccine in Brazilian Adults |
Bryan Greenhouse, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Malaria Serology evaluation |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Identifying Human Breast Carcinogens Using Exposomics |
Laura Fejerman, PhD |
Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma |
|
Occupational and Environmental Disease, Immunology |
|
|
p24 Antigen and Alternative Markers in Infants, Vietnam |
Annette Sohn, MD |
HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Molecular basis of tissue interactions that regulate craniofacial development |
|
Genetics |
|
|
Enhancing Control of HIV by Inhibiting TRAIL |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Evolution and Inhibition of Serine Beta-Lactamase Activity |
Adam Renslo, PhD |
Opportunistic Infection, Drug and Diagnostics Development |
|
|
Life After Pediatric Sepsis Evaluation, LAPSE |
|
Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
Core Laboratory for Sputum Quality Assurance and Sputum Analysis |
|
Noncommunicable and/or Chronic Disease, Chronic Respiratory Disease, Drug and Diagnostics Development |
|
|
BSL3 upgrading for Live-attenuated poliovirus testing |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
ACTG A5335s Specialty Lab |
Diane Havlir, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
Initiation of allergic immunity by parasites |
Richard Locksley, MD |
Immunology |
|
|
HINT: HIV Immune Networks Team Modeling Core |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
Gilead Sciences Research Scholars Program in Cystic Fibrosis. |
Oren Rosenberg, MD, PhD |
Immunology |
|
|
HIV cure with CCR5 negative human IPS hematopoietic stem cells |
|
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Mechanisms of Neutrophil Activation |
|
Immunology |
|
|
Multicenter Uveitis Steroid Treatment (MUST) Trial |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Vertical Transmission of Zika Virus: Histopathological Investigations at the Maternal- Fetal Interface |
Stephanie Valderramos, MD, PhD |
Infectious Disease, Drug and Diagnostics Development, Immunology |
|
|
Molecular Methods for Cervical Cancer Screening in HIV+ Women |
Nancy Hessol, MSPH |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
California Precision Medicine Consortium |
Atul Butte, MD, PhD |
Drug and Diagnostics Development |
|
|
A feasibility study evaluating a reservoir storage system for continuous oxygen delivery in Uganda |
Melissa Morgan Medvedev, MD, MSc |
Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Antigen Decoding by T cells |
|
Immunology |
|
|
A Randomized, Double Blinded, Active-Controlled Study of Cb-183,315 in Patients with Clostridium-difficile-Associated Diarrhea |
|
Infectious Disease, Drug and Diagnostics Development |
|
|
Improve the Cho Expression of a ScFv Fragment by Optimizing the DNA Sequence of the ingle chain variable fragment ScFv and/or Leader Sequence |
|
Drug and Diagnostics Development, Immunology |
|
|
Genetic and molecular pathophysiology of ATS |
Louis Ptacek, MD |
Cardiovascular Disease, Genetics |
|
|
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Structural Basis of Protease-Activated Receptor Function |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus |
Henry Chambers, MD |
Genetics |
|
|
NSW-QB3 Rosenman Institute Scholarship Program |
Regis Kelly, MD |
Drug and Diagnostics Development, Residencies, Fellowships, and Postdoctoral Training |
|
|
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Parirenyatwa |
Zvavahera Chirenje, MD, FRCOG |
Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
Sputum Transcriptomic Expression Profiling in Study 31 (STEPS 31) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer |
Katherine Van Loon Steitz, MD, MPH |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Gene-Environment Analyses of Early Life Exposures and Asthma in Ethnically Diverse Children |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Occupational and Environmental Disease, Genetics, Pediatrics |
|
|
Mother-child genetic contributions to autoimmunity |
|
Immunology |
|
|
Antimalarial drugs in Ugandan populations |
Melissa Conrad, PhD |
HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics |
|
|
Clinical Trial of the Infuse/Mastergraft Delayed Healing Device with Rigid Internal Fixation in the Treatment of Tibial Delayed Healing ("Tibia Study") |
Saam Morshed, MD, MPH, PhD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
HARC Center: HIV Accessory and Regulatory Complexes |
Alan Frankel, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology |
|
|
Novel approaches to identify host genes required for Chlamydia pathogenesis |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Drug and Diagnostics Development |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Optogenetic dissection of the growth and activation network in T cells |
|
Immunology |
|
|
Sustained Strengthening of Public Health Laboratory, Transfusion Services and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
Kayla Enriquez, MD, MPH |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Drug and Diagnostics Development, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training International Scholars and Clinicians |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
Placental Malaria: The Role of Macrophages in Placental Inflammation - RSDP Valderramos Burroughs Wellcome Fund |
Stephanie Valderramos, MD, PhD |
Malaria, Immunology |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education |
|
|
Oxygen Sensors and P450 Monooxygenases in Mycobacertium tuberculosis |
|
Tuberculosis, Immunology |
|
|
Identification of Signaling Pathways Associated with Lyme Disease |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Elucidating the Fundamental Biology of Memory Regulatory T cells in Skin |
|
Cancer/Oncology, Immunology |
|
|
A point of care assay for chlamydia to assure prompt treatment in at risk minorities |
Julius Schachter, PhD |
Infectious Disease, Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
Defining critical events in early HIV infection-effects of alcohol and early ART |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology, Substance Abuse |
|
|
Newborn Screening Program for Sickle Cell |
James Huang, MD |
Genetics, Newborn and Infant Health |
|
|
Mechanisms of Spatial Cognitive Impairment in Neurodegenerative Disease |
|
Drug and Diagnostics Development, Dementia and Cognitive Impairment |
|
|
Protein homeostasis mechanisms underlying enterovirus replication and evolution |
Raul Andino-Pavlovsky, PhD |
Genetics |
|
|
Snakebite treatment in Nepal |
Tommaso Bulfone, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Targeting Allosteric Sites to Modulate Protein Interactions and Function |
Charles Craik, PhD |
Drug and Diagnostics Development |
|
|
MR Metabolic Imaging of Response to Targeted Therapies in GBM |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
he Efficacy of Various Antibiotics at Targeting Wolbachia for the Treatment of Lymphatic Filariasis |
Emma Gunderson, MS |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Murine Neuroblastoma Models for Preclinical Therapeutics |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
A pilot study of DNA methylation and response to treatment in RA |
|
Immunology |
|
|
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia |
Henry Chambers, MD |
Infectious Disease, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
NP25737 A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis |
|
Noncommunicable and/or Chronic Disease, Immunology, Pediatrics |
|
|
Metabiota - Viral Surveillance for the PREDICT Program 20150410 |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory |
Bryan Greenhouse, MD |
Malaria, Immunology, Pediatrics |
|
|
Creating Maps of 4D Brain Images to Unravel Dementia Heterogeneity of Aging HIV Population |
Victor Valcour, MD, PhD |
Drug and Diagnostics Development, Dementia and Cognitive Impairment |
|
|
A Web-Based Automatic Virtual Screening System |
|
Drug and Diagnostics Development |
|
|
HIV-Specific T-Cell Responses in Rectal Mucosa |
Elizabeth Sinclair, PhD |
HIV/AIDS, Immunology |
|
|
Mass Spectrometry Tools in Pursuit of Salivary Biomarkers of Sjogren Syndrome |
|
Oral Health, Immunology |
|
|
Extending ASD risk locus discovery to the non-coding genome |
|
Genetics, Neurology and Mental Health |
|
|
Biocompatibility of Implantable Renal Replacement Devices |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology |
Atul Butte, MD, PhD |
Cancer/Oncology, Immunology |
|
|
Provider Practices in Non-Malarial Fevers: A Pilot Study in Malawi |
Kimberly Baltzell, RN, PhD, MS |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Immunology |
|
|
The Amyotrophic Lateral Sclerosis (ALS)/Parkinsonism-Dementia Complex of Guam: Exploring the Mechanism of a Rare Tauopathy |
Michael Geschwind, MD, PhD |
Genetics, Neurology and Mental Health |
|
|
Prostate Cancer Therapeutic Clinical Investigation "First in Man" |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Impact of Sirolimus (Rapamycin) on HIV-1 Persistence and Immune Function |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Development of Antimalarial Drug Leads Through Inhibition of Food Vacuole Falcipains |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Building an Implantable Artificial Kidney |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Quantitative mapping of interactions between dengue virus and its hosts |
|
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Philippine-UC Collaboratory for Device Innovation (Education/Training Award) |
Michael Harrison, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Malaria, Drug and Diagnostics Development, Genetics, Training International Scholars and Clinicians |
|
|
Immunomodulation of transplant rejection by anti-CD3 mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
LOC-IMPAACT Leadership Group |
Francesca Aweeka, PharmD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development |
|
|
High-Throughput Phenotyping and Continuous Evolution Systems |
Adam Abate, PhD |
Drug and Diagnostics Development |
|
|
Developing a Macrofilaricidal Drug for Onchocerciasis Using Anacor's Novel Oxaborole Technology |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Development of the infant gastrointestinal virome and shedding of oral polio and rotavirus vaccines in Bangladeshi and US infants |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Micro- and Nano-Structured Biopolymer Thin Film Devices for Small Molecule Drug Delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Biomarkers for PTSD in Female Iraq and Afghanistan Veterans |
|
Drug and Diagnostics Development, Trauma and PTSD |
|
|
Towards Therapeutics for Neurodegenerative Diseases |
|
Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment |
|
|
Treatment of SLE with ajulemic acid,a non-psychoactive cannabinoid derivative |
|
Immunology |
|
|
Genome wide association study of breast cancer subtype and survival in Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Genetics, Epidemiology and Surveillance |
|
|
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages |
|
Tuberculosis, Immunology |
|
|
Tissue Biopsy Samples from Head and Neck Cancers |
Charles Chiu, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Flexible Resorbable Organic and Nanomaterial Therapeutic Systems (FRONTS) |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
Reactivation of latent HIV using recombinant galectin-9 |
|
HIV/AIDS, Immunology |
|
|
Self-Assembled DNA Devices for Nanoscale Manipulation of Immune Signal Transduction |
|
Drug and Diagnostics Development |
|
|
RAPID: Ebola virus population structure, genetic diversity and evolution |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Accurate, long-read sequencing with droplet-microfluidic barcoding |
Adam Abate, PhD |
Infectious Disease, Cancer/Oncology, Genetics |
|
|
Automated smear-positive tuberculosis diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Discovering Drugs for Prion Diseases |
|
Drug and Diagnostics Development |
|
|
Trefoil Factors Regulate Th2 Immunity |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Immunology |
|
|
UCSF/UCB Joint Graduate Group in Bioengineering |
Tejal Desai, PhD |
Drug and Diagnostics Development, Residencies, Fellowships, and Postdoctoral Training |
|
|
Patient beliefs about the relationship between Chronic Non-Cancer Pain (CNCP) management, alcohol and marijuana use in safety net, primary health care settings |
Jorge Ramirez, MD, MPH, MS |
Drug and Diagnostics Development |
|
|
Exploring the role of a novel, polymorphic protein family in M. tuberculosis pathogenesis |
|
Tuberculosis, Immunology |
|
|
Mechanism, Specificity, and Inhibition of Cytochrome P450 |
|
Drug and Diagnostics Development, UCSF Professional Education |
|
|
Whole Blood/Serum Samples from Patients with Hepatitis |
Charles Chiu, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Genetic Determinants of Capecitabine Toxicity |
|
Genetics, Pharmacology and Drug Treatment |
|
|
Large-Scale Production and In-Vivo Characterization of Therapeutic DNA Nanodevices |
|
Drug and Diagnostics Development |
|
|
Characterization of Familial Advanced Sleep Phase Syndrome |
Louis Ptacek, MD |
Genetics |
|
|
Integrating computation and genetics to quantify specificity in protein networks |
Nevan Krogan, PhD, MSc |
Genetics |
|
|
Medical and Graduate Student Preceptorship - Mok |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Interferon-independent mechanisms of malaria restriction by helper T cells |
Mike McCune, MD, PhD |
HIV/AIDS, Malaria, Immunology |
|
|
Hologic - Analytical sensitivity comparison of a new molecular assay for Plasmodium detection with a qualitative nested PCR assay and a quantitative PCR assay 20150330 |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Biomarkers for Malaria Eradication (BIOME) |
Bryan Greenhouse, MD |
Malaria, Drug and Diagnostics Development |
|
|
Comparative Effectiveness of Rapid Diagnostics for Tuberculosis in Uganda |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Mechanisms of B Cell Responses in Autoimmune Disease |
|
Oral Health, Immunology |
|
|
Schistosome Research |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Streamlined TB Diagnosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing |
Charles Chiu, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
UCSF Cutaneous Immunology Core: OSM Project |
|
Opportunistic Infection, Cancer/Oncology, Immunology |
|
|
The Role of Continuous Phenotypic Variation in Structural Defects of the Face |
|
Genetics, Newborn and Infant Health |
|
|
Mechanism of enterovirus replication |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development |
|
|
Genetics of Brazilian Populations |
Mark Seielstad, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Immunology |
|
|
An Ultrasensitive in Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Health Professional Research Preceptorship |
|
Immunology, Residencies, Fellowships, and Postdoctoral Training |
|
|
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB In Vivo |
Payam Nahid, MD, MPH |
Zoonosis, Emerging Disease, and Drug Resistance, Tuberculosis, Drug and Diagnostics Development |
|
|
Biostatistical analysis of Mycobacterium Tuberculosis Biomarkers for Diagnosis and Cure |
Rada Savic, PhD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Identifying and targeting HIV persistence in T Cell subsets during ART |
Steven Deeks, MD |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
QB3 Entrepreneurship, Train the trainers program |
Regis Kelly, MD |
Drug and Diagnostics Development, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Discovery of benzoxaboroles for the treatment of cryptosporidiosis |
Philip J. Rosenthal, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Gilead HCAT Support-SOMA Project |
James Dilley, MD |
Genetics |
|
|
A Novel Myeloid Subset Mediating Tolerance to Malaria |
|
Malaria, Immunology |
|
|
Establishing a Core Facility for Virus Detection and Discovery |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Alfred P. Sloan Foundation Fellowship |
|
Genetics |
|
|
Silicon Dialyzer Prototype |
Shuvo Roy, PhD |
Drug and Diagnostics Development |
|
|
An Evolutionary-Developmental Approach to Stem Cells Using Teeth As a Model |
|
Oral Health, Genetics, Training International Scholars and Clinicians |
|
|
High throughput proteomics to dissect Chlamydia-host cell interactions |
Joanne Engel, MD, PhD |
Infectious Disease, Sexually Transmitted Infections (STIs), Genetics, Risk Reduction and Prevention |
|
|
Nanoporous Films for Ocular Drug Delivery |
Tejal Desai, PhD |
Eye Disease and Blindness, Drug and Diagnostics Development |
|
|
International Collaboration in Chemistry: the Chemical Basis for Allosteric Regulation of G Protein Coupled Receptors |
|
Drug and Diagnostics Development |
|
|
Cross-Sectional Examination of Cerebrospinal Fluid Kinetic Biomarkers of Axonal Transport for Amyotrophic Lateral Sclerosis (Als) Diagnosis and Progression |
Richard Price, MD |
Drug and Diagnostics Development |
|
|
Mechansims of poliovirus replication |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Noncommunicable and/or Chronic Disease, Genetics |
|
|
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation. |
Lydia Zablotska, MD, MPA, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Barriers to point-of-care G6PD testing for P.vivax malaria in Malaysia: a qualitative study |
Jessica Jaswal, MS |
Malaria, Drug and Diagnostics Development, Access or Barriers to Care |
|
|
Dual Energy X-Ray Absorptiometry (DXA) Scan Analysis and Quality Control Review for NHANES 2011-2016 |
|
Drug and Diagnostics Development |
|
|
An optogenetic method to rapidly and reversibly titrate protein levels in cells |
|
Genetics |
|
|
Multimodal Imaging of Antibody-Mediated Therapy for Japanese Encephalitis Virus |
Michael Wilson, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Preparing for Human Studies Using the Spinlab Polarizer |
|
Drug and Diagnostics Development |
|
|
Mobile Phone Platform for Genomic Disease Detection |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Genetics |
|
|
CCD Study- RNA Sequencing |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients |
Steven Deeks, MD |
HIV/AIDS, Immunology, Women's Health |
|
|
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
PAAR4Kids-Pharmacogenomics Research Network |
|
Cancer/Oncology, Genetics, Pharmacology and Drug Treatment |
|
|
Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Collaborative Network for Clinical Research on Immune Tolerance |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
An Automated High Throughput Phenotypic Screen for Schistosomiasis Drug Discovery |
|
Infectious Disease, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Mechanisms of B Cell Responses in Autoimmune Disease: C12-ALE05-CSF |
|
Immunology |
|
|
Designing a Sonographic Medium for Low Resource Settings |
|
Drug and Diagnostics Development |
|
|
Preventing Fucose-Dependent Binding of Aspergillus and Pseudomonas to Lung Mucin |
|
Infectious Disease, Chronic Respiratory Disease, Genetics |
|
|
Collaborative Network for Clinical Research on Immune Tolerance - Offcampus Portion |
Jeffrey Bluestone, PhD |
Diabetes, Immunology |
|
|
Genome-Wide Association Study to Examine Genes Associated with An Increased Risk of Febrile Seizure in Children Following Measles-Containing Vaccines |
Mark Seielstad, PhD |
Infectious Disease, Transfusion Medicine, Immunology, Pharmacology and Drug Treatment, Pediatrics, Epidemiology and Surveillance |
|
|
Deep Sequencing Clinical Analysis Tool for Infectious Disease |
|
Infectious Disease, Drug and Diagnostics Development |
|
|
CHRP Disparities Initiative: UCSF CFAR Conference Award |
Paul Volberding, MD |
HIV/AIDS, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients |
Adithya Cattamanchi, MD |
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
A 6 month Multi-center, Open-label Safety Study of VIMOVO in Adolescents |
|
Immunology, Adolescent Health |
|
|
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Whole Genome Sequencing in Multiple Sclerosis |
|
Genetics |
|
|
Recent Thymic Emigrants of the CD4 T-Cell Lineage |
Mike McCune, MD, PhD |
Immunology |
|
|
Clin 0004 Characterization of Viral Hemorrhagic Fevers of Unknown Origin |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Clin 0003 Identification and Characterization of a Putative Novel Poxvirus in the DRC |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Development of Human mABs to CXCR1 and CXCR2 |
|
Immunology |
|
|
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Structure and Engineering of Natural Product Cytochrome P450 |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU |
Zvavahera Chirenje, MD, FRCOG |
HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention |
|
|
Donation of Primaquine for the UCSF-Sponsored Phase 2A Dose Escalation Study of the Efficacy, Safety and Pharmacokinetics of Low Single-Dose Primaquine for Gametocytocidal Activity against P. Falciparum in Sub-Saharan Africa |
Roland Gosling, PhD, MS, MD |
Malaria, Drug and Diagnostics Development |
|
|
Pathogen Discovery in PREDICT Human and Wildlife samples to Detect and Identify Viruses Present, Both Known and Novel |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Stem Cell differentiation to thymic epithelium for inducing immune tolerance to stem cells |
|
Immunology |
|
|
Nanoscale Science and Engineering Center (NSEC) |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Health Professional Research Preceptorship |
|
Immunology |
|
|
Development of Regulatory T-Cells for Treatment of Autoimmune Disease |
Jeffrey Bluestone, PhD |
Immunology, Pharmacology and Drug Treatment |
|
|
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Epi4K: Gene discovery in 4,000 Epilepsy Genomes (4/7) |
Elliott Sherr, MD, PhD |
Cardiovascular Disease, Genetics |
|
|
Collaborative Molecular Genetic Investigation of Pediatric Myelodysplatic Syndromes |
|
Genetics, Neurology and Mental Health |
|
|
Identification and Validation of Targets of Phenotypic High Throughput Screening |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Global Innate Immune Responses to HIV-1 Infection |
Nevan Krogan, PhD, MSc |
HIV/AIDS, Immunology |
|
|
Fellowship in Clinical Biochemical Genetics |
|
Genetics, Residencies, Fellowships, and Postdoctoral Training |
|
|
Comprehensive Diagnostics for Viral Encephalitis/Meningitis |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
Lead Identification to Clinical Candidate Selection: Drugs for Chagas' Disease |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
DNA methylation profiling in Rheumatoid Arthritis |
|
Immunology |
|
|
Bioresponsive Scaffold Designed to Promote Bone Regeneration Through a Cartilage Intermediate |
|
Drug and Diagnostics Development |
|
|
Comprehensive Assay Platform and Database for Drug Transporter Interaction Studies |
|
Drug and Diagnostics Development |
|
|
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development, Epidemiology and Surveillance |
|
|
Chemicals with Potential Activity against Malaria Parasites |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Broad Spectrum Antivirals Targeting Envelope Proteolysis and Viral Uncoating |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach |
Nevan Krogan, PhD, MSc |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics |
|
|
Diagnostic Antibody for Type A Botulism |
|
Infectious Disease, Drug and Diagnostics Development |
|
|
Lysosomal Storage Disorders Genetic Counselor Fellowship (Genzyme 43737) |
|
Noncommunicable and/or Chronic Disease, Genetics, Pediatrics |
|
|
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Genetics, Risk Reduction and Prevention |
|
|
Public Health Research, Epidemiology, and Surveillance for Hemoglobinopathies (PHRESH) Sickle Cell Disease (SCD)/ Thalassemia Case Reporting |
James Huang, MD |
Infectious Disease, Genetics, Health Systems Strengthening, Risk Reduction and Prevention |
|
|
Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA Registry): Lupus Nephritis Consensus Treatment Plan Maintenance Phase |
|
Immunology |
|
|
Whole Genome Analyses for Asthma in Latino Populations |
Esteban Burchard, MD, MPH |
Chronic Respiratory Disease, Occupational and Environmental Disease, Genetics |
|
|
Nanoporous Capsules for the Investigation of Macroencapsulation Parameters |
Tejal Desai, PhD |
Diabetes, Drug and Diagnostics Development |
|
|
Nanoengineered Thin Film Devices for Ocular Drug Delivery |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Novel Technologies to Increase the Accessibility and Accuracy of Tuberculosis Diagnostic Services in Hanoi Province, Vietnam |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Novel Maltodextrin-Based, Bacterial Targeting Probes for Bioimaging of Viable MTB in Vivo |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
Microfluid Chip Design |
Adam Abate, PhD |
Drug and Diagnostics Development |
|
|
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-Daily Oral Aripiprazole in Children and Adolescents with Tourette's Disorder |
|
Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health |
|
|
Sanofi-Aventis SAR650894 Program - Research Component |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Nanostructured Polymer Films and Microneedles |
Tejal Desai, PhD |
Drug and Diagnostics Development |
|
|
Development of Targeted Anti-Cancer Platinum Analogs |
|
Cancer/Oncology, Drug and Diagnostics Development |
|
|
K777 for the Treatment of Chagas' Disease, IND-enabling Studies and IND Submission |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Early Diagnosis of Human Prion Disease |
Michael Geschwind, MD, PhD |
Infectious Disease, Drug and Diagnostics Development |
|
|
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis |
Nisha Acharya, MD |
Eye Disease and Blindness, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Wave 80 Fingerstick Pilot Study |
Christopher Pilcher, MD |
Drug and Diagnostics Development |
|
|
Whole Genome Sequencing of Multiplex Schizophrenia Pedigrees from an Isolated Population |
William Byerley, MD |
Genetics, Neurology and Mental Health |
|
|
Philips Mra Research Plan B-9 (Dose Aware) |
Saam Morshed, MD, MPH, PhD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens |
Charles Chiu, MD, PhD |
Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Development of Human mAbs to Target Cardiomyocytes and Cardiac Fibroblasts |
|
Cardiovascular Disease, Immunology |
|
|
Initiation of Allergic Immunity by Parasites |
Richard Locksley, MD |
Immunology |
|
|
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans |
|
HIV/AIDS, Tuberculosis, Drug and Diagnostics Development |
|
|
HLA-A Low Resolution Typing |
|
Surgery and Anesthesia, Immunology |
|
|
Mesalamine to Reduce T Cell Activation in HIV Infection |
Peter Hunt, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Escaneo genomico completo del paciente con diabetes tipo 2 para la busqueda de nuevos marcadores de asociacion con enfermedad |
Esteban Burchard, MD, MPH |
Diabetes, Genetics |
|
|
Task Order Agreement No. CRB-DCR01-S-09-00325 |
Diane Havlir, MD |
Drug and Diagnostics Development |
|
|
Pivotal Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea |
|
Drug and Diagnostics Development |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Drug and Diagnostics Development |
|
|
Identifying Intermediate Phenotypes for Compulsive Hoarding |
Carol Mathews, MD |
Genetics, Neurology and Mental Health |
|
|
Translation Regulation in Giardia lamblia |
|
Infectious Disease, Genetics |
|
|
Characterizing the Role of Immune Activation in HIV Persistence |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Evaluation of a Novel Automated PCR Method for Infectious Disease Diagnostics |
|
Drug and Diagnostics Development |
|
|
DSC09r-178688 GEH Novel MR Technology (7T & C13) |
|
Drug and Diagnostics Development |
|
|
A New Field Assay to Diagnose and Monitor Schistosomiasis |
|
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
International Fellowship Program in Drug Development |
|
Drug and Diagnostics Development, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
Identification of Novel Therapeutics Molecules against Old and New World Cutaneous Leishmaniasis |
Adam Renslo, PhD |
Drug and Diagnostics Development |
|
|
Identification of the CD8+ Cell Anti-HIV Factor (CAF) |
|
HIV/AIDS, Immunology |
|
|
Neuroform Angiographic Analysis (Subset of MAPS study data) |
|
Cardiovascular Disease, Drug and Diagnostics Development |
|
|
RNA Interference and High-Content Image Analysis to Discover New Drug Targets to Treat the Tropical Disease Schistosomiasis |
|
Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
RNAi as an Intercellular Antiviral Defense Mechanism |
Raul Andino-Pavlovsky, PhD |
Infectious Disease, Genetics |
|
|
Epigenetic Profiling of Multiple Cell and Tissue Types in Sjögren's Syndrome |
|
Genetics |
|
|
Viral Discovery in Human and Animal Samples |
Charles Chiu, MD, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Trial of T.cruzi DNA Vaccine in Experimental Model of Disease Challenge Infection |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Point-of-Care Diagnostics for STI and UTI |
Julius Schachter, PhD |
Drug and Diagnostics Development |
|
|
Origami Female Condom User-Preference (FUP) Study |
|
Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Neurosteroids in Health and Disease |
|
Genetics, Neurology and Mental Health |
|
|
Microbicide Pregnancy Registry-Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health |
|
|
Secretion of Virulence Factors by Mycobacterium tuberculosis |
|
Infectious Disease, HIV/AIDS, Tuberculosis, Genetics |
|
|
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis |
Adam Renslo, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Solitaire With the Intention For Thrombectomy (SWIFT) Study |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
Treating HIV-Infected Elite Controllers as a Model of HIV Remission |
|
HIV/AIDS, Immunology |
|
|
Trypanosome Drug Development Consortium |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development |
|
|
Bipolar Endophenotypes in Population Isolates |
|
Genetics, Neurology and Mental Health |
|
|
Dissecting the HLA contribution to Rheumatoid Arthritis |
|
Genetics |
|
|
Dissecting the HLA Contribution to Rheumatoid Arthritis |
|
Genetics |
|
|
Pharmacogenomics of Antimalarial Drugs |
Sunil Parikh, MD, MPH |
Malaria, Genetics, Pharmacology and Drug Treatment |
|
|
Pfizer International Growth Study (KIGS) - Protocol TRN 87-052-45 (CCID A6281276) |
|
Drug and Diagnostics Development |
|
|
Replication fidelity mutants as attenuated poliovirus seeds for IPV production |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Diagnostic Imaging Core Laboratory Services: Ischemic Stroke Neuroflow Study, Vasospasm Subjects |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
Siglec-F and Resolution of Allergic Inflammation |
Homer Boushey, MD |
Immunology, Genetics |
|
|
Janssen/Sakanari - flubendazole study 20150930 |
Judy Sakanari, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Effectiveness of QuantiFERON-TB Gold (QFT-G) in Contact Tracing |
Elizabeth Fair, PhD, MPH |
Tuberculosis, Drug and Diagnostics Development |
|
|
CNS Immune / Inflammatory Biomarkers in HIV Controllers |
Richard Price, MD |
HIV/AIDS, Immunology |
|
|
UCSF/Ragon Collaboration on HIV "Elite" Controllers |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics |
|
|
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
Valley Fever Vaccine Project 2010 |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
HIV Entry Inhibitors: A New Therapeutic Option |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Viruses in Breast Fluid: Biomarkers for Breast Cancer? |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients |
|
HIV/AIDS, Immunology |
|
|
Core B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Immunology |
|
|
Metagenomics for Identification of Infectious Triggers of KLS |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT |
Steven Deeks, MD |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Genetics of Schizophrenia in Oceanic Palau |
William Byerley, MD |
Genetics, Neurology and Mental Health, Pediatrics |
|
|
HIV Incidence Testing in Hair |
Christopher Pilcher, MD |
HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence |
|
|
Population Genetic Mapping of Tourette Syndrome |
|
Genetics, Neurology and Mental Health |
|
|
Innate Effector Function and HIV-1 Control |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Testing novel adjuvants to enhance mucosal immunity elicited by inactivated poliovirus vaccine (IPV) |
Raul Andino-Pavlovsky, PhD |
Drug and Diagnostics Development, Immunology |
|
|
Novel Strategies for defining the Role of HLA in SLE |
|
Noncommunicable and/or Chronic Disease, Genetics |
|
|
Identification of Viruses in an Asthma Cohort |
Charles Chiu, MD, PhD |
Chronic Respiratory Disease, Drug and Diagnostics Development |
|
|
Tuberculosis Trials Consortium (TBTC) |
Payam Nahid, MD, MPH |
Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Case-Control Association Studies and Genetic Confounding |
Esteban Burchard, MD, MPH |
Genetics, Risk Reduction and Prevention |
|
|
Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis in Adults |
Adithya Cattamanchi, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Rhbmp2 vs. AutograpH for Critical Size Tibial Defects: a Multi-Center Randomized Trial |
Amir Matityahu, MD |
Surgery and Anesthesia, Drug and Diagnostics Development |
|
|
Clinical Pharmacology, Drug Action and Pharmacogenetics |
Neal Benowitz, MD |
Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|
Targeting Cysteine Proteases--Antiparasitic Chemotherapy |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Microbicide Pregnancy Registry--Microbicide Trials Network |
Juan Vargas, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning |
|
|
Immunological Targeting of APOBEC Proteins to Cure HIV Infection |
|
HIV/AIDS, Immunology |
|
|
Admixture Mapping Development and Testing in African American SLE |
|
Genetics |
|
|
Immunogenetic Studies of Autoimmune Disease |
|
Immunology |
|
|
EBV BMRF-2 Protein in Infection of Oral Epithelial Cells |
Sharof Tugizov, PhD |
Noncommunicable and/or Chronic Disease, Drug and Diagnostics Development |
|
|
Valley Fever Vaccine Project |
George Rutherford, MD |
Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development |
|
|
Develop Clinical Evidence of Substantial Equivalence to Predicate Devices |
Suellen Miller, PhD, CNM, MHA |
Drug and Diagnostics Development |
|
|
Transcriptional Responses of Parasite and Host during Intestinal Colonization and Invasion by Entamoeba histolytica |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Chemoprophylaxis and HIV-Host Interactions [II] |
|
HIV/AIDS, Immunology |
|
|
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 |
Raul Andino-Pavlovsky, PhD |
Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development |
|
|
Ultra-Low Viral Detection Using the Abbott RealTime HIV-1 Assay |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Metagenomics for Detection and Discovery of Viruses Associated with Acute Gastroenteritis in Mexico |
Charles Chiu, MD, PhD |
Drug and Diagnostics Development |
|
|
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia |
|
Immunology |
|
|
Sputum Processing Methods |
|
Tuberculosis, Drug and Diagnostics Development |
|
|
Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) |
|
Opportunistic Infection, Drug and Diagnostics Development |
|
|
Probing Below the Surface: Development of a Molecular Diagnostic Assay to Detect Emergent Viral Escape Variants |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Development of Falcipain Inhibitors as Antimalarial Drugs |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
CORE B: Intracellular Pathogens and Innate Immunity |
Joseph Derisi, PhD |
Tuberculosis, Immunology |
|
|
Phase 2, Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Immunogenicity of Two Doses of 3?-aminomethylnicotine-P. aeruginosa r Exoprotein A Conjugate Vaccine (NicVAX?) in 2 Different Dosing Schedules in Smokers |
|
Drug and Diagnostics Development, Smoking and Tobacco |
|
|
Host Protein Degradation by Schistosome Parasites |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
UCSF-FIND Uganda Project |
Laurence Huang, MD |
Tuberculosis, Drug and Diagnostics Development |
|
|
Elite Controllers |
Steven Deeks, MD |
HIV/AIDS, Immunology, Genetics |
|
|
Utility of Rapid Diagnostic Tests for Malaria |
Heidi A. Hopkins, PhD |
Malaria, Drug and Diagnostics Development, Pediatrics |
|
|
Novel Anti-Malarials by Combinatorial Pharmacogenomics |
Joseph Derisi, PhD |
Infectious Disease, Malaria, Drug and Diagnostics Development |
|
|
Valganciclovir to Reduce T Cell Activation in HIV Infection |
Peter Hunt, MD |
HIV/AIDS, Drug and Diagnostics Development, Immunology |
|
|
Double-Stranded RNA Virus in Giardia |
|
Genetics |
|
|
HIV Vaccine Trials Network - Laboratory Personnel Support |
|
Immunology |
|
|
Selective Destruction of Cytochrome P450 by Drugs |
|
Drug and Diagnostics Development |
|
|
Structural Biology and Targeted Drug Design for AIDS |
|
HIV/AIDS, Drug and Diagnostics Development |
|
|
Herpesviral Gene Expression in Kaposi's Sarcoma |
|
HIV/AIDS, Cancer/Oncology, Genetics |
|
|
HIV Controllers: A Potential Model for HIV Eradication |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
3D-FSE-zeta equipment |
William Dillon, MD |
Drug and Diagnostics Development |
|
|
T Regulatory Cells and T Cell Activation in HIV Disease |
Steven Deeks, MD |
HIV/AIDS, Immunology |
|
|
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" |
Philip Hopewell, MD |
Tuberculosis, Immunology, Systematic Reviews and Guideline Development |
|
|
Optimization of Cysteine Protease Inhibitors Targeting Trypanosoma Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Development and Testing of New Medications for the Treatment of Emerging Infectious Diseases [I] |
Philip J. Rosenthal, MD |
Infectious Disease, Drug and Diagnostics Development |
|
|
High Throughput Assay for Screening Compounds Against T. Brucei |
|
Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
Examination of genome instability in Plasmodium Falciparum using functional genomics |
|
Malaria, Genetics |
|
|
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Drug and Diagnostics Development |
|
|
Population Genetics of the PO1 Locus of SIV and HIV-1 |
Eric Delwart, PhD |
HIV/AIDS, Transfusion Medicine, Genetics, Epidemiology and Surveillance |
|
|
Regulation of Human Thymic Function in Vivo |
Mike McCune, MD, PhD |
Immunology |
|
|
Phase II Double Blinded, Placebo-Controlled, Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an Anti-IgE mAb |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Effects of Viral Escape on Memory T-Cell Muturation |
Eric Delwart, PhD |
Immunology |
|
|
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 |
Mike McCune, MD, PhD |
HIV/AIDS, Immunology |
|
|
Novel Tetracyclines as Antimalarial Agents |
Philip J. Rosenthal, MD |
Malaria, Drug and Diagnostics Development |
|
|
UCSF Comprehensive Center for Immunologic Diseases (CCID) |
Jeffrey Bluestone, PhD |
Immunology |
|
|
Vaccine to Prevent HIV Infection in Pregnancy and Newborns |
Raul Andino-Pavlovsky, PhD |
HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health |
|
|
Creating Polyketide Antibiotic Diversity by Engineering Cytochrome P450 Enzymes / UC Discovery |
|
Immunology |
|
|
Sensitivity of Electronic Alcohol Diagnosis |
Constance Weisner, DrPH |
Drug and Diagnostics Development |
|
|
Swaziland Serology Technical Assistance |
Michelle Hsiang, MD |
Malaria, Drug and Diagnostics Development |
|
|
High Throughput Screening of Philippine Terrestrial and Marine Organisms for Antimalarial Properties and Identification of Novel Drug Targets |
Joseph Derisi, PhD |
Malaria, Drug and Diagnostics Development |
|
|